期刊文献+

青年缺血性卒中患者中法布里病出现率的调查 被引量:2

Prevalence of ischemic stroke in young adults and Fabry disease
原文传递
导出
摘要 目的:调查法布里病及α-半乳糖苷酶基因( GLA基因)变异在国人青年缺血性卒中患者中的出现情况。方法本研究连续纳入2012年10月至2014年3月就诊于首都医科大学宣武医院卒中单元的年龄在18~55岁的缺血性卒中患者,收集其临床资料,并采集外周血,提取DNA,进行PCR扩增GLA基因7个外显子及相邻内含子,并进行测序,在缺血性卒中人群中进行法布里病出现率的调查。结果(1)共连续纳入符合条件的青年缺血性卒中患者269例,其中脑梗死239(88.8%)例,短暂性脑缺血发作及后循环缺血30(11.2%)例,平均年龄(44±8)岁,男女比例为4∶1(男216例,占80.3%;女53例,占19.7%),TOAST分型以大动脉粥样硬化为主,占55.4%;(2)在所检269例青年缺血性卒中患者中,未检出一例明确法布里病致病突变。有12例患者出现c.-12G>A点突变,20例患者c.-10C>T点突变,这两个位点均位于外显子1的5′端非翻译区,该2个功能多态位点在不同TOAST分型中分布差异有统计学意义。结论法布里病在国人青年缺血性卒中患者中的出现率并不高,c.-10C>T位点突变在国人不同TOAST卒中亚型中存在差异,其意义还有待于进一步研究。 Objective To investigate the prevalence of Fabry disease and GLA gene mutations in young patients with ischemic stroke.Methods A total of 269 consecutive hospitalized patients of ischemic stroke,aged between 18-55 years,were recruited.DNA was extracted from peripheral blood.And 7 exons and flanking introns of α-galactosidase gene ( GLA ) were sequenced.Results The cases were cerebral infarction (n=239,88.8%) transient ischemic attack and posterior circulation ischemia (n=30,11.2%). There were 216 males and 53 females with a mean age of 44 ±8years.Large artery atherosclerosis was predominant at 55.4%according to the TOAST classifications.Among them,there were c.-12G〉A point mutation (n=12) and c.-10C〉T mutation (n=20).These two sites were located in the 5 ′end of non-untranslated region in exon 1.Both loci were polymorphic loci.No disease-causing mutations were detected.Conclusion The prevalence of Fabry disease in young stroke patients is not high as in Western countries;there has some difference in TOAST types between patients with c.-10C〉T mutation and without, further studies are needed to testing the significance.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第47期3717-3720,共4页 National Medical Journal of China
基金 国家自然科学基金(81371291) 北京市215人才项目学科带头人 北京市“十百千”人才项目“十”人才 神经内科国家临床重点专科资助
关键词 缺血性卒中 青年 法布里病 患病率 Ischemic stroke Young adults Fabry disease Prevalence
  • 相关文献

参考文献15

  • 1Blaydon D, Hill J, Winchester B. Fabry disease : 20 novel GLA mutations in 35 families[ J]. Hum Mutat,2001,18 :459.
  • 2Spada M, Pagliardini S, Yasuda M, et al. High incidence of later- onset fabry disease revealed by newborn screening [ J ]. Am J Hum Genet, 2006,79 : 31-40.
  • 3Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey[ J]. Eur J Clin Invest,2004,34:236-242.
  • 4Mehta A, Ginsberg L. Natural history of the cerebrovascular complications of Fabry disease [ J ]. Acta Paediatr Suppl,2005,94: 24-7 ; discussion 9-10.
  • 5Sims K, Politei J, Banikazemi M, et al. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry[ J ]. Stroke, 2009,40 : 788 -794.
  • 6Wu G,Pang S,Feng X,et al. Genetic analysis of lysosomal alpha- galactosidase A gene in sporadic Parkinson's disease[ J]. Neurosci Lett,2011,500 : 31-35.
  • 7赵倩,安丰双,安贵鹏.心肌肥厚患者中Fabry病发病状况的临床研究[J].山东大学学报(医学版),2010,48(3):116-119. 被引量:1
  • 8Ginsberg L. Nervous system manifestations of Fabry disease: data from FOS - the Fabry Outcome Survey//Mehta A, Beck M, Sunder-Plassmann G, eds. SourceFabry Disease : Perspectives from 5 Years of FOS[ M]. Oxford: Oxford Pharma Genesis,2006:23.
  • 9Davies JP,Winchester BG, Malcolm S. Sequence variations in the first exon of alpha-galactosidase A [ J ]. J Med Genet, 1993,30 : 658-663.
  • 10安贵鹏,安丰双,张运,邹永新,张澄,姜红,冯进波,王荣.两个新发现的致Fabry病基因突变位点[J].中华心血管病杂志,2007,35(3):212-215. 被引量:1

二级参考文献54

共引文献53

同被引文献39

  • 1Peters FP,Vermeulen A,Kho TL.Anderson-Fabry's disease:alpha-galactosidase deficiency[J].Lancet,2001,357(9250):138-140.
  • 2Germain DP,Giuqliani R.Safety and pharmacodynamic effects of a pharmacological chaperone on alpha-galactosidase A activity and globotriaosylceramide clearance in Fabry disease:report from two phase 2 clinical studies[J].Orphanet J Rare Dis,2012,7(1):91-101.
  • 3Germain DP,Boucly C,Carlier RY,et al.Enzyme replacement therapy of lysosomal storage diseases[J]Rev Med Interne,2010,31(Suppl 2):279-291.
  • 4Biegstraaten M,van Schaik IN,Wieling W,et al.Autonomic neuropathy in Fabry disease:a prospective study using the autonomic symptom profile and cardiovascular autonomic function tests[J].BMC Neurol,2010,10(2):38-46.
  • 5Kocen RS,Thomas PK.Peripheral nerve involvement in Fabry's disease[J].Arch Neurol,1970,22(1):81-88.
  • 6Liquori R,Di Stasi V,Bugiardini E,et al.Small fiber neuropathy in female patients with Fabry disease[J].Muscle Nerve,2010,41(3):409-412.
  • 7Rota E,Morelli N,Terlizzi E,et al.Missing link:could the elusive Wartenberg's neuritis be a peripheral nerve variant of Fabry's disease?[J].Neurol India,2014,62(2):219-221.
  • 8Buechner S,Moretti M,Burlina AP,et al.Central nervous system involvement in Anderson–Fabry disease:a clinical and MRI retrospective study[J].J Neurol Neurosurg Psychiatry,2008,79(11):1249-1254.
  • 9Tuttolomondo A,Pecoraro R,Simonetta I,et al.Anderson-Fabry Disease:A Multiorgan Disease[J].Curr Pharm Des,2013,19(33):5974-5996.
  • 10Burlina AP,Sims KB,Politei JM,et al.Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain:the report of an expert panel[J].BMC Neurol,2011,11(3):61-71.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部